Nanomaterials: small particles show huge possibilities for cancer immunotherapy

• Published in: Journal of nanobiotechnology Vol. 20; no. 1; pp. 1 - 38
• Main Authors: Chen, Ziyin, Yue, Ziqi, Yang, Kaiqi, Li, Shenglong
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 16.11.2022; BioMed Central; BMC
• Subjects: Aging; Aluminum; Anti-tumor treatment; Antigens; Bioavailability; Cancer; Cancer immunotherapy; Cancer therapies; Care and treatment; Cell membranes; Chemoradiotherapy; Chemotherapy; Death; Dendritic cells; Design and construction; Drug resistance; Experiments; Globalization; Health aspects; Hydrogels; Immune system; Immunity; Immunosuppressive agents; Immunotherapy; Lymphatic system; Lymphocytes; Medical prognosis; Membranes; Methods; Morbidity; Morphology; Mortality; Nanomaterials; Nanoparticles; Nanotechnology; Oncology; Patients; Proteins; Radiation therapy; Review; Self-assembly; Side effects; Signal transduction; Technology application; Tumor immunosuppressive microenvironment; Tumor microenvironment; Tumors; Vaccines; China
• ISSN: 1477-3155; 1477-3155
• DOI: 10.1186/s12951-022-01692-3

With the economy's globalization and the population's aging, cancer has become the leading cause of death in most countries. While imposing a considerable burden on society, the high morbidity and mortality rates have continuously prompted researchers to develop new oncology treatment options. Anti-tumor regimens have evolved from early single surgical treatment to combined (or not) chemoradiotherapy and then to the current stage of tumor immunotherapy. Tumor immunotherapy has undoubtedly pulled some patients back from the death. However, this strategy of activating or boosting the body's immune system hardly benefits most patients. It is limited by low bioavailability, low response rate and severe side effects. Thankfully, the rapid development of nanotechnology has broken through the bottleneck problem of anti-tumor immunotherapy. Multifunctional nanomaterials can not only kill tumors by combining anti-tumor drugs but also can be designed to enhance the body's immunity and thus achieve a multi-treatment effect. It is worth noting that the variety of nanomaterials, their modifiability, and the diversity of combinations allow them to shine in antitumor immunotherapy. In this paper, several nanobiotics commonly used in tumor immunotherapy at this stage are discussed, and they activate or enhance the body's immunity with their unique advantages. In conclusion, we reviewed recent advances in tumor immunotherapy based on nanomaterials, such as biological cell membrane modification, self-assembly, mesoporous, metal and hydrogels, to explore new directions and strategies for tumor immunotherapy.